OneSource Specialty Pharma

OneSource Specialty Pharma is an Indian specialty drug/CDMO that focuses on drug-device combination products, providing the formulation, manufacturing and development of complex drugs, as well as the device assembly and testing of multiple injection pens/autoinjectors. Its CPHI data discloses that it has approximately 40 million cassettes + injection pen devices, 28 million PFS capacity at USFDA and EMA-approved plants, and supplies from both India and Poland. The company completed 18 successful inspections in 24 months and has the drug-device combination capability from development to commercial supply.